Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region – 2024 to 2029

SKU: GMS-2105

Format: PDF

Overall Rating
4.5/5

OVERVIEW

The global diagnostic companion market is projected to hit USD 7.78 billion by 2025, rising over the forecast period at a CAGR of 13.34%. The advantages of companion diagnostics, the the need for targeted treatment, the the importance of personalized medicine, the the global incidence of cancer and the ever-rising application areas of companion diagnostics drive the growth of the global companion diagnostics industry.

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 1

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 2

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 3

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 4

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 5

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 6

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 7

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 8

TABLE OF CONTENT

1 Global Companion Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Companion Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Companion Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Companion Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Companion Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Companion Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Companion Diagnostics Market – By Product & Service (Market Size – &
million/billion)
8.1 Assay kits & Reagents
8.2 Software & Services

9 Global Companion Diagnostics Market – By Technology
9.1 Polymerase Chain Reaction (PCR)
9.2 In Situ Hybridization (ISH)
9.3 Next-Generation Sequencing (NGS)
9.4 Immunohistochemistry (IHC)
9.5 Others

10 Global Companion Diagnostics Market – By Indication
10.1 Cardiovascular
10.2 Neurological Diseases
10.3 Cancer
10.4 Infectious Diseases
10.5 Others

11 Global Companion Diagnostics Market – By End-User
11.1 Pharmaceutical & Biopharmaceutical Companies
11.2 Reference Laboratories
11.3 CROs
11.4 Others

12 Global Companion Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Companion Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Companion Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 F. Hoffmann-La Roche AG
14.3 Agilent Technologies, Inc.
14.4 QIAGEN N.V.
14.5 Danaher Corporation
14.6 Abbott Laboratories, Inc.
14.7 Biomérieux SA
14.8 Myriad Genetics, Inc.
14.9 Sysmex Corporation
14.10 Almac Group
14.11 Illumina Inc.
14.12 Company 11 & more

15 Global Companion Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00$5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The global diagnostic companion market is projected to hit USD 7.78 billion by 2025, rising over the forecast period at a CAGR of 13.34%. The advantages of companion diagnostics, the the need for targeted treatment, the the importance of personalized medicine, the the global incidence of cancer and the ever-rising application areas of companion diagnostics drive the growth of the global companion diagnostics industry.

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 9

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 10

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 11

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 12

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 13

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 14

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 15

Companion Diagnostics Market by Indication (Cardiovascular Disease, Breast, Lung & Colorectal Cancer), Product & Service (Software & Service, Assay, Kit), Technology (ISH, PCR, NGS, IHC), End-User (Pharma Companies, CRO), Region - 2024 to 2029 16

TABLE OF CONTENT

1 Global Companion Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Companion Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Companion Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Companion Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Companion Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Companion Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Companion Diagnostics Market – By Product & Service (Market Size – &
million/billion)
8.1 Assay kits & Reagents
8.2 Software & Services

9 Global Companion Diagnostics Market – By Technology
9.1 Polymerase Chain Reaction (PCR)
9.2 In Situ Hybridization (ISH)
9.3 Next-Generation Sequencing (NGS)
9.4 Immunohistochemistry (IHC)
9.5 Others

10 Global Companion Diagnostics Market – By Indication
10.1 Cardiovascular
10.2 Neurological Diseases
10.3 Cancer
10.4 Infectious Diseases
10.5 Others

11 Global Companion Diagnostics Market – By End-User
11.1 Pharmaceutical & Biopharmaceutical Companies
11.2 Reference Laboratories
11.3 CROs
11.4 Others

12 Global Companion Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Companion Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Companion Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 F. Hoffmann-La Roche AG
14.3 Agilent Technologies, Inc.
14.4 QIAGEN N.V.
14.5 Danaher Corporation
14.6 Abbott Laboratories, Inc.
14.7 Biomérieux SA
14.8 Myriad Genetics, Inc.
14.9 Sysmex Corporation
14.10 Almac Group
14.11 Illumina Inc.
14.12 Company 11 & more

15 Global Companion Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations

Download our eBook: Market Mastery

Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.

Related Research Reports